DJIA 17,156.85 24.88 0.15%
NASDAQ 4,562.19 9.43 0.21%
S&P 500 2,001.57 2.59 0.13%
market minute promo

359.10 3.63 (1.02%)

REAL-TIME: Last trade at

company name or ticker

Recent Quotes

REGN $359.10 1.02%
Company Photos
(Click to zoom)
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $357.30
Previous Close $355.47
Daily Range $354.29 - $360.89
52-Week Range $257.69 - $369.31
Market Cap $36.3B
P/E Ratio 100.99
Dividend (Yield) $0.00 (0.0%)
Volume 659,723
Average Daily Volume 636,360
Current FY EPS $7.95





Regeneron Pharmaceuticals, Inc. (REGN) Description

The Company is a biopharmaceutical company that discovers, develops, and intends to commercialize pharmaceutical products for the treatment of serious medical conditions. Website:

News & Commentary

Why I'd Avoid Pfizer Inc. Stock Despite the Dividend

Dividend stocks are an important part of a well-rounded portfolio. Yet some high-yielding stocks are better left alone. Here is a look at one top name in healthcare that investors should avoid for the time being.

Regeneron Gets Breakthrough Therapy Status for Eylea - Analyst Blog Daily Round Up 9/17/14: HTWR, REGN, IO, HALO

10 stocks for conservative investors who want to make a lot of money

Deutsche Bank Is Bullish On Gilead Sciences, Inc. And Other Biotech Stocks

Two Promising Gene Therapy Stocks Tackling Eye Disease

Deutsche Bank’s 4 Top Biotech Stocks to Buy for This Year and 2015

Bayer/Regeneron Looking for Eylea Label Expansion in Japan - Analyst Blog

Sanofi: Riding The Growth Trend

There Is Further Upside Potential In Regeneron Pharmaceuticals

See More REGN News...

REGN's Top Competitors

REGN $359.10 (1.02%)
Current stock: REGN
AMGN $140.71 (0.99%)
Current stock: AMGN
BIIB $327.58 (0.21%)
Current stock: BIIB
CELG $92.26 (-0.33%)
Current stock: CELG